Photo-Plethysmographic (PPG) Camera to Monitor Heart Rate, Respiration Rate and Oxygen Saturation in Infants
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The researchers want to determine if ambient light, PPG, can monitor reliably heart rate, respiration rate and oxygen saturation (SpO2) in infant patients in a hospital setting.
| Condition | Intervention |
|---|---|
|
Child Development |
Device: photo-plethysmographic (PPG) |
| Study Type: | Observational |
| Study Design: | Observational Model: Case-Only Time Perspective: Prospective |
| Official Title: | A Pilot Study Using Photo-plethysmographic (PPG) Camera to Monitor Heart Rate, Respiration Rate and Oxygen Saturation in Infants. |
- ambient light, PPG can monitor reliably heart rate, respiration rate and oxygen saturation (SpO2) [ Time Frame: 24 hours ] [ Designated as safety issue: No ]
| Enrollment: | 20 |
| Study Start Date: | September 2009 |
| Study Completion Date: | December 2009 |
| Primary Completion Date: | December 2009 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
| monitoring |
Device: photo-plethysmographic (PPG)
photo-plethysmographic (PPG) camera to monitor heart rate, respiration rate and oxygen saturation in infants
|
Detailed Description:
The plethysmographic signal is typically strong on children. This provides a reliable heart rate monitor. However, to measure oxygen saturation, a quantitative value of the strength at two wavelength regions (green and red) is required. It is also not known if the normal ambient light is spectrally appropriate to analyze the video signals for oxygenation. With the current prototype of our system, we can monitor heart rate reliably and estimate oxygen saturation in adults, using normal artificial light or daylight, entering through a window. Heart rate and oxygen saturation will be extracted from the PPG signals off the cheek, forehead or hand while the respiration rate may be retrieved from the PPG signal off the chest area.
Eligibility| Ages Eligible for Study: | up to 1 Week |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
infant
Inclusion Criteria:
- infant in NICU at CHOC hospital
Exclusion Criteria:
- non-infant
Contacts and Locations| United States, California | |
| CHOC | |
| Orange, California, United States, 92868 | |
| Principal Investigator: | Stuart Nelson, MD | Beckman Laser Institute University of California Irvine |
More Information
No publications provided
| Responsible Party: | Montana Compton, Administrative Nurse Research Coordinator Beckman Laser Institute, University of California, Irvine |
| ClinicalTrials.gov Identifier: | NCT00989859 History of Changes |
| Other Study ID Numbers: | D/EB-02495-05 |
| Study First Received: | October 2, 2009 |
| Last Updated: | October 28, 2011 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by University of California, Irvine:
|
monitoring |
ClinicalTrials.gov processed this record on May 19, 2013